HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Novel Monocarboxylate Transporter Inhibitor as a Potential Treatment Strategy for γ-Hydroxybutyric Acid Overdose.

AbstractPURPOSE:
Monocarboxylate transporter (MCT) inhibition represents a potential treatment strategy for γ-hydroxybutyric acid (GHB) overdose by blocking its renal reabsorption in the kidney. This study further evaluated the effects of a novel, highly potent MCT inhibitor, AR-C155858, on GHB toxicokinetics/toxicodynamics (TK/TD).
METHODS:
Rats were administered GHB (200, 600 or 1500 mg/kg i.v. or 1500 mg/kg po) with and without AR-C155858. Breathing frequency was continuously monitored using whole-body plethysmography. Plasma and urine samples were collected up to 8 h. The effect of AR-C155858 on GHB brain/plasma partitioning was also assessed.
RESULTS:
AR-C155858 treatment significantly increased GHB renal and total clearance after intravenous GHB administration at all the GHB doses used in this study. GHB-induced respiratory depression was significantly improved by AR-C155858 as demonstrated by an improvement in the respiratory rate. AR-C155858 treatment also resulted in a significant reduction in brain/plasma partitioning of GHB (0.1 ± 0.03) when compared to GHB alone (0.25 ± 0.02). GHB CLR and CLoral (CL/F) following oral administration were also significantly increased following AR-C155858 treatment (from 1.82 ± 0.63 to 5.74 ± 0.86 and 6.52 ± 0.88 to 10.2 ± 0.75 ml/min/kg, respectively).
CONCLUSION:
The novel and highly potent MCT inhibitor represents a potential treatment option for GHB overdose.
AuthorsNisha Vijay, Bridget L Morse, Marilyn E Morris
JournalPharmaceutical research (Pharm Res) Vol. 32 Issue 6 Pg. 1894-906 (Jun 2015) ISSN: 1573-904X [Electronic] United States
PMID25480120 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • AR C155858
  • Antidotes
  • Monocarboxylic Acid Transporters
  • Thiophenes
  • Uracil
  • Sodium Oxybate
Topics
  • Administration, Intravenous
  • Administration, Oral
  • Animals
  • Antidotes (pharmacology)
  • Brain (metabolism)
  • Cell Line
  • Drug Overdose (drug therapy, metabolism)
  • Kidney (drug effects, metabolism)
  • Male
  • Metabolic Clearance Rate
  • Monocarboxylic Acid Transporters (antagonists & inhibitors, metabolism)
  • Rats, Sprague-Dawley
  • Renal Reabsorption (drug effects)
  • Respiratory Insufficiency (chemically induced, drug therapy, metabolism, physiopathology)
  • Respiratory Rate (drug effects)
  • Sodium Oxybate (administration & dosage, pharmacokinetics, toxicity)
  • Thiophenes (pharmacology)
  • Tissue Distribution
  • Uracil (analogs & derivatives, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: